Denver, Colorado
Cancer clinical trials in Denver, CO
131 cancer studies are recruiting participants at sites in Denver as of November 16, 2026, according to ClinicalTrials.gov. Oncology Research Hub can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Denver at a glance
- 131 studies are recruiting at a site in Denver.
- By phase: Phase 1 (34), Phase 1/2 (30), Phase 2 (11), Phase 2/3 (4), Phase 3 (38), No phase (3), Observational (11). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (91), university, hospital or other (33), government (7).
- By research area: Breast Cancer (41), Lymphoma (28), Lung Cancer (27), Prostate Cancer (16), Pancreatic Cancer (10), Melanoma (9).
- Most recent update to one of these records: November 16, 2026.
Breast cancer studies recruiting in Denver
Basic details from each study's public record (the 30 most recently updated of 131). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- UCHealth - Cherry Creek
- Registry record
- NCT06058377 · updated
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study sites
- Intermountain Health Cancer Center Saint Joseph ( Site 0062) · Rocky Mountain Cancer Centers (RMCC) ( Site 8006)
- Registry record
- NCT06966700 · updated
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study site
- Sarah Cannon Research Institute at HealthONE
- Registry record
- NCT07503808 · updated
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- SWOG Cancer Research Network
- Study sites
- Colorado Blood Cancer Institute · National Jewish Health-Main Campus · Porter Adventist Hospital
- Registry record
- NCT03723928 · updated
The Vanguard Study: Testing a New Way to Screen for Cancer
- No phase
- Ages 45 to 75
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Kaiser Permanente-Franklin
- Registry record
- NCT06995898 · updated
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Phase 1
- Ages 19 and older
- All sexes
- Sponsor
- NiKang Therapeutics, Inc.
- Study site
- SCRI at HealthOne
- Registry record
- NCT06586957 · updated
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- NiKang Therapeutics, Inc.
- Study site
- Sarah Cannon Research Institute at HealthONE
- Registry record
- NCT07029399 · updated
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Observational
- Ages 40 to 75
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- AdventHealth Porter
- Registry record
- NCT05334069 · updated
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Phase 3
- Ages 18 to 60
- Female participants
- Sponsor
- NRG Oncology
- Study sites
- Saint Joseph Hospital - Cancer Centers of Colorado · UCHealth - Cherry Creek
- Registry record
- NCT05879926 · updated
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Wake Forest University Health Sciences
- Study sites
- Colorado Blood Cancer Institute · Kaiser Permanente-Franklin · Rocky Mountain Cancer Centers-Midtown
- Registry record
- NCT06418204 · updated
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Sarah Cannon Research Institute at HealthOne
- Registry record
- NCT06465069 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Denver, CO on ClinicalTrials.gov.
Lung cancer studies recruiting in Denver
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Kaiser Permanente-Franklin · National Jewish Health-Main Campus
- Registry record
- NCT04267848 · updated
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Kaiser Permanente-Franklin
- Registry record
- NCT06498635 · updated
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Bayer
- Study site
- Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's
- Registry record
- NCT06914128 · updated
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study sites
- Rocky Mountain Cancer Centers LLP · Rocky Mountain Cancer Centers,LLP
- Registry record
- NCT07144280 · updated
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study sites
- Presbyterian/St Lukes Medical Center · Sarah Cannon Research Institute at HealthONE
- Registry record
- NCT07519655 · updated
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Kaiser Permanente-Franklin
- Registry record
- NCT04181060 · updated
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kumquat Biosciences Inc.
- Study site
- Sarah Cannon Cancer Institute at HealthONE
- Registry record
- NCT06720987 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Denver, CO on ClinicalTrials.gov.
Prostate cancer studies recruiting in Denver
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Amgen
- Study site
- Rocky Mountain Cancer Centers
- Registry record
- NCT04221542 · updated
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Regeneron Pharmaceuticals
- Study site
- Sarah Cannon Research Institute (SCRI)
- Registry record
- NCT03972657 · updated
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Sarah Cannon Research Institute 1
- Registry record
- NCT06800313 · updated
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Phase 3
- Ages 18 and older
- Male participants
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- Kaiser Permanente-Franklin
- Registry record
- NCT06931340 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Denver, CO on ClinicalTrials.gov.
Lymphoma studies recruiting in Denver
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Nurix Therapeutics, Inc.
- Study site
- Colorado Blood Institute
- Registry record
- NCT07221500 · updated
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Colorado Blood Cancer Institute ( Site 7000)
- Registry record
- NCT07519772 · updated
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Phase 2
- Ages 1 to 30
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
- Registry record
- NCT04546399 · updated
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
- Phase 3
- Ages 5 to 60
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
- Registry record
- NCT05675410 · updated
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Colorado Blood Cancer Institute
- Registry record
- NCT07101328 · updated
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Lyell Immunopharma, Inc.
- Study site
- Colorado Blood Cancer Institute
- Registry record
- NCT07188558 · updated
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Colorado Blood Cancer Institute
- Registry record
- NCT07226843 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Denver, CO on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Denver
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Incyte Corporation
- Study site
- Investigative Site US071
- Registry record
- NCT07522073 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Denver, CO on ClinicalTrials.gov.
Ask about studies near Denver
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Colorado
All Colorado locations
314 studies recruiting across 31 cities.
Aurora
167 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections